Shippers Ask Regulators to Kill the $85B Rail Deal. Brighthouse Widens on BRCD Chatter.

On August 6, the Alliance for Chemical Distribution, American Chemistry Council, American Fuel & Petrochemical Manufacturers, The Fertilizer Institute, and the National Industrial Transportation League jointly asked the STB to summarily deny the $85B UP-NS application — arguing the railroads haven't provided enough evidence to clear even the preliminary "prima facie" public-interest threshold. This is a procedural ask, not a merits argument: if granted, it ends the deal early without a full review, a faster and sharper risk than the "long, slow process" framing that's dominated this story so far.

Context that cuts both ways: this follows separate late-July completeness challenges from rival Class I railroads (BNSF, CPKC, CN, CSX), which UP/NS rebutted as "baseless" in a 36-page filing. And Union Pacific's new binding agreement with CN — transferring Norfolk Southern's TRRA/Kansas City Terminal interests to CN — directly resolves one specific ownership concern and may reduce CN's incentive to keep opposing. The STB's own May 28 finding that the application was complete is a real data point against this motion succeeding. Genuinely two-sided week: real new opposition, real new de-risking, in the same seven days.

BHF widened this week after a Capital Forum article and trader chatter flagged accounting questions tied to BRCD (Brighthouse Reinsurance Company of Delaware, a long-standing captive reinsurance affiliate) and a claim that Aquarian isn't committed to inject capital beyond its filed plan. Unconfirmed — neither company has commented — but it sent us back through the actual merger agreement, and what's in there is sharper than we expected: the Burdensome Condition definition enumerates five specific triggers, and one names BRCD directly — any non-de-minimis adverse change to BRCD's reinsurance operations or the company's statutory accounting practices itself qualifies as grounds Aquarian isn't required to accept. That's a close textual match to this week's chatter, not a loose inference. The other four triggers: a Company Material Adverse Effect; capital contributions beyond the filed Form A Business Plans; guaranties or minimum-capital requirements beyond those plans; and non-de-minimis dividend restrictions. The agreement does require both sides to negotiate in good faith before either can invoke a Burdensome Condition to walk — real leverage, not an automatic exit.

We also confirmed the real outside date: September 6, 2026, extendable to December 6 only in specified circumstances — tighter than the soft year-end target commonly assumed, and in real tension with DFS's typical 12-18 month review pace for deals this size. The market's ~13-15% spread has reflected real completion risk all along; what changed this week is a clearer read on the specific mechanics driving it. Moving BHF from #6 to #3 in the Risk/Reward ranking to reflect that.

AAUC is up roughly 20% off its July 29 termination-day low, accelerating sharply on August 6 when the Globe and Mail reported chairman Peter Marrone is open to selling Allied Gold piecemeal — explicitly compared to how he sold Yamana Gold to Agnico Eagle and Pan American Silver after an earlier deal fell through. On the same day's earnings call, Marrone said the company is "more advanced and a better company" than when the Zijin deal was first signed in January. Add Kurmuk's imminent startup and the ~9.2% Zijin strategic stake closing around August 10, and the standalone story here has genuinely improved in the two weeks since the deal broke — not a consolation prize, a real re-rating.

Two weeks ago we flagged transpacific spot rates doubling off May lows and asked whether it would show up in the stock before ZIM's Aug 19 earnings confirm it in the numbers. This week, it did: ZIM just had its best week since December, up over 7%, compressing the Hapag-Lloyd spread from ~39% to ~30%. The Israeli government opposition to the deal itself hasn't moved an inch — this is purely the standalone-value half of the thesis working, exactly as laid out. Aug 19 remains the date that tells us how much of the rate spike actually reaches the income statement.

ICE's $167.00/share, ~$6.0B all-cash acquisition of MarketAxess is one of five new additions this week — unanimous board approval on both sides, fully committed financing, a 33% premium. But the ~2.6% spread looks tight against a genuine Second Request risk we don't think is fully priced in. Horizontal overlap: combined ICE/MarketAxess share of electronic fixed-income execution approaches Tradeweb's, the category's other major player. Vertical concern layered on top: ICE already supplies the pricing data, indices, and benchmarks used across fixed income, and would now also own a leading execution venue.

The clearest signal both sides are taking this seriously: ICE agreed to a $327.4M regulatory termination fee if antitrust clearance isn't obtained — the kind of number that only gets negotiated when both sides expect genuine exposure, not a formality. If a Second Request lands, the review could extend timeline well past the announced H1 2027 target. Deal economics look solid; the open question is whether regulators see the concentration the way the market is currently pricing it.

Orla Mining's combination with Equinox Gold completed July 31; Electronic Arts' $210/share take-private closed August 4, exactly on schedule; Fidelity Bank completed its acquisition of Affinity Bancshares July 31. Between closures and new adds, the tracker's net count held roughly steady at 72.

Two weeks ago we flagged $67.50 as the one number to watch on this deal — the floor of the collar protecting Iridium holders' $27 stock-leg value, which RKLB had breached intraday in late July after falling nearly 60% from its late-May record. This week RKLB clawed all the way back, rallying into the high-$70s and low-$80s on a new $397M US Space Force contract, continued Electron launch cadence, and broad space-sector strength.

That move puts RKLB comfortably back inside the $67.50–$112.50 protected band, where the exchange ratio floats specifically to hold the stock leg at a fixed $27.00 regardless of RKLB's exact price. Practical effect: the full $54.00 nominal deal value is largely locked in again, with a real cushion (~15-20%+ above the floor, versus ~5% two weeks ago) rather than sitting on the edge of losing that protection. RKLB reports Q2 earnings August 10 — the next event that could move the stock meaningfully within the band.